← Eichor
Study identifier: NCT04231006 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Salvage HDR for Locally Recurrent Prostate Cancer

Condition: Prostate Cancer  ·  Sponsor: Aarhus University Hospital

PhaseNA
Planned participants50
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The study offers focal salvage brachytherapy for prostate cancer patients with a local recurrence after primary defintive radiotherapy

This description comes directly from the study's public registry record.

Talk to the study team

Simon Buus, MD  ·  +4540465291  ·  simbuu@rm.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Department of OncologyAarhus, Region Midt, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04231006